Navidea Reports 2016 Third Quarter Financial Results (Navidea Biopharmaceuticals Inc)

Edit Public Technologies 03 Nov 2016
(Source. Navidea Biopharmaceuticals Inc). DUBLIN, Ohio--(BUSINESS WIRE)--Nov ... Navidea reported total revenue for the third quarter of 2016 of $8.5 million, including Lymphoseek (technetium Tc 99m tilmanocept) injection sales revenue of $6.7 million ... ET ... Lymphoseek® (technetium Tc 99m tilmanocept) injection, Navidea's first commercial product from the Manocept platform, was approved by the FDA in March 2013 and in Europe in November 2014....

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters ...

Edit PR Newswire 02 Nov 2016
NEW YORK, Nov. 2, 2016 /PRNewswire/ -- The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the years, the nuclear medicine/radiopharmaceuticals ... ....

Lantheus Holdings, Inc. Reports 2016 Third Quarter Financial Results

Edit Stockhouse 01 Nov 2016
market ... Ms ... LMI’s key products include the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs....

Lantheus Holdings, Inc. Reports 2016 Third Quarter Financial Results (Lantheus Holdings Inc)

Edit Public Technologies 01 Nov 2016
(Source ... market ... LMI's key products include the echocardiography contrast agent DEFINITYVial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite(Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs....

Change of Company Address (Cyclopharm Limited)

Edit Public Technologies 31 Oct 2016
(Source. Cyclopharm Limited). 31 October 2016. The Manager ... Telephone ... The Technegas technology is a structured ultra‐fine dispersion of radioactive labeled carbon, produced by using dried Technetium‐ 99m in a carbon crucible, micro furnaced for a few seconds at around 2,700oC ... Mo‐99 generators are used in diagnostic imaging to harvest Technetium‐99m, or Tc‐99m, which is the primary isotope used in diagnostic imaging throughout the world....

TT100 advances technological excellence (Department of Science and Technology - Republic of South Africa)

Edit Public Technologies 28 Oct 2016
(Source. Department of Science and Technology - Republic of South Africa) Details Published on Friday, 28 October 2016 12.46 ... 'Africahas a billion people and is one of the fastest growing regions in the world ... But it is not sufficient ... Winners in the Small Enterprise Category included Technetium, X/procure Sofware SA, Khonology, ColonyHQ and Systemic Logic Innovation Agency ... Enquiries. ... Follow us on Twitter @dstgovza ... Technetium (Pty) Ltd....

Navidea Biopharmaceuticals to Announce Third Quarter 2016 Financial Results on November 3, 2016

Edit Stockhouse 27 Oct 2016
Navidea Biopharmaceuticals to Announce Third Quarter 2016 Financial Results on November 3, 2016. - Conference call with investment community to follow at 8.30 a.m. ET -. Navidea Biopharmaceuticals, Inc. (NYSE MKT ... ET ... Event ... Date/Time ... ET. Webcast Link. ... Lymphoseek® (technetium Tc 99m tilmanocept) injection, Navidea’s first commercial product from the Manocept platform, was approved by the FDA in March 2013 and in Europe in November 2014....

Navidea Biopharmaceuticals to Announce Third Quarter 2016 Financial Results on November 3, 2016 (Navidea Biopharmaceuticals Inc)

Edit Public Technologies 27 Oct 2016
(Source. Navidea Biopharmaceuticals Inc). - Conference call with investment community to follow at 8.30 a.m. ET -. DUBLIN, Ohio--(BUSINESS WIRE)--Oct. 27, 2016-- Navidea Biopharmaceuticals, Inc. (NYSE MKT ... ET ... Event ... Date/Time. November 3, 2016; 8.30 a.m. ET ... Lymphoseek (technetium Tc 99m tilmanocept) injection, Navidea's first commercial product from the Manocept platform, was approved by the FDA in March 2013 and in Europe in November 2014....

Nuclear Medicine/Radiopharmaceuticals Market Worth 7.27 Billion USD by 2021

Edit PR Newswire 25 Oct 2016
PUNE, India, October 25, 2016 /PRNewswire/ -- According to a new market research report "Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application ... ....

Lantheus Holdings to Present at 25th Annual Credit Suisse Healthcare Conference (Lantheus Holdings Inc)

Edit Public Technologies 24 Oct 2016
(Source ... LMI's key products include the echocardiography contrast agent DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs....

Windtree Releases Data from Lung Deposition Study in Non-Human Primates Demonstrating Uniform Distribution of Aerosolized KL4 Surfactant in all Regions of the Lung (Windtree Therapeutics Inc)

Edit Public Technologies 24 Oct 2016
(Source. Windtree Therapeutics Inc) ... Study Provides Further Validation of Company's Proprietary Aerosol Delivery Technology ... (Nasdaq ... Data from this study were generated from an in vivo distribution study using three NHPs, cynomolgus macaques, which received three-to-ten minute exposures of technetium-labeled KL4 surfactant that was aerosolized using the same model ADS currently being used in the AEROSURF phase 2b clinical program....

OECD Responds to Questions Raised by the U.S. National Academy of Sciences Report Titled “Molybdenum-99 for Medical Imaging” (SNMMI - Society of Nuclear Medicine and Molecular Imaging)

Edit Public Technologies 20 Oct 2016
The report, among other findings, states, 'The committee judges that there is a substantial (>50 percent) likelihood of severe molybdenum-99/technetium-99m supply shortages after October 2016, lasting at least until current global suppliers complete their planned capacity expansions.' The findings of the National Academies also indicate a similar ......

Lantheus Holdings to Host Third Quarter 2016 Earnings Conference Call on November 1, 2016 at 4:30 p.m. Eastern Time (Lantheus Holdings Inc)

Edit Public Technologies 18 Oct 2016
(Source ... LMI's key products include the echocardiography contrast agent DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs....
×